UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010377
Receipt number R000010891
Scientific Title Therapeutic effect of jizusoippo for symptoms of Yusho patients exposed to dioxins
Date of disclosure of the study information 2013/04/15
Last modified on 2021/04/07 10:02:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Therapeutic effect of jizusoippo for symptoms of Yusho patients exposed to dioxins

Acronym

Effect of jizusoippo for Yusho

Scientific Title

Therapeutic effect of jizusoippo for symptoms of Yusho patients exposed to dioxins

Scientific Title:Acronym

Effect of jizusoippo for Yusho

Region

Japan


Condition

Condition

Yusho disease

Classification by specialty

Medicine in general Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effectiveness of Jizusoippo on the symptoms of Yusho.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

respiratory, skin, and neurological symptoms, general fatigue, and QOL

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients take 2.5g of Jizusoippo three times a day after each meal for 6months.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients aged 20 years or older who fulfilled the diagnostic criteria for Yusho established by the National Study Group for the Therapy of Yusho and give their written informed consents are eligible.

Key exclusion criteria

Patients are not eligible if they have serious diseases (malignant neoplasms, hepatic disorders, renal disorders, or blood disorders), have been treated with any other Kampo formulae, or are women with pregnancy or nursing women. Patients who are judged to have an ineligible health condition by medical doctors are excluded.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masutaka Furue

Organization

Kyushu University Hospital

Division name

Dermatology

Zip code


Address

3-1-1, Maidashi, Higashiku, Fukuoka

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Uchi

Organization

Kyushu University Hospital

Division name

Research and Clinical Center for Yusho

Zip code


Address

3-1-1, Maidashi, Higashiku, Fukuoka

TEL

092-642-5211

Homepage URL


Email



Sponsor or person

Institute

Kyushu University Hospital

Institute

Department

Personal name



Funding Source

Organization

The Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 10 Month 11 Day

Date of IRB

2012 Year 10 Month 31 Day

Anticipated trial start date

2013 Year 01 Month 01 Day

Last follow-up date

2014 Year 01 Month 08 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 04 Month 01 Day

Last modified on

2021 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010891


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name